Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

990
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
990
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

568
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
568
Amyloid Fibrils03:03

Amyloid Fibrils

10.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.9K
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Subviral Agents01:29

Subviral Agents

235
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
235
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.1K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cranberry Polyphenol Extract (CPE) Oral Rinse Improves Salivary Microbiome in 6-n-Propylthiouracil (PROP) Non-Tasters and Palatability of Aronia Juice.

International journal of molecular sciences·2026
Same author

Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA.

medRxiv : the preprint server for health sciences·2026
Same author

New Insights into the Combined Antiviral Effect of Extracts from <i>Nerium oleander</i> and <i>Boswellia sacra</i> Against Respiratory Syncytial Virus: A Preliminary Report.

Pathogens (Basel, Switzerland)·2026
Same author

Beyond One-Size-Fits-All: Addressing Methodological Constraints in Novel Antimicrobials Discovery.

Antibiotics (Basel, Switzerland)·2025
Same author

Liposomal Delivery of a Biotechnological <i>Lavandula angustifolia</i> Miller Extract Rich in Rosmarinic Acid for Topical Herpes Simplex Therapy.

Antioxidants (Basel, Switzerland)·2025
Same author

Seeking Correlation Among Porin Permeabilities and Minimum Inhibitory Concentrations Through Machine Learning: A Promising Route to the Essential Molecular Descriptors.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Oct 25, 2025

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.2K

Parkinson's Disease: A Prionopathy?

Sarah Vascellari1, Aldo Manzin1

  • 1Microbiology and Virology Unit, Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy.

International Journal of Molecular Sciences
|August 7, 2021
PubMed
Summary

Parkinson's disease involves misfolded alpha-synuclein (α-synuclein) forming toxic aggregates. This review explores the prion-like spread of these aggregates, linking Parkinson's to other neurological disorders.

Keywords:
Parkinson’s diseasegut microbiotaprion-like mechanismprotein misfolding co-factorsα-synuclein

More Related Videos

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

8.7K
Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

626

Related Experiment Videos

Last Updated: Oct 25, 2025

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

16.2K
Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

8.7K
Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

626

Area of Science:

  • Neuroscience
  • Protein Misfolding Diseases
  • Neurodegenerative Disorders

Background:

  • Parkinson's disease (PD) pathogenesis involves α-synuclein misfolding and aggregation.
  • These aggregates form intraneuronal inclusions, leading to dopaminergic neuronal loss.
  • A prion-like mechanism is increasingly implicated in the progression of PD and other neurological disorders.

Purpose of the Study:

  • To compare the characteristics of α-synuclein and prion protein.
  • To discuss cofactors influencing protein structure remodeling.
  • To elucidate pathogenetic mechanisms underlying neurodegeneration in PD.

Main Methods:

  • Literature review comparing α-synuclein and prion protein.
  • Analysis of cofactors affecting protein structure.
  • Discussion of neurodegenerative pathways.

Main Results:

  • α-synuclein shares key characteristics with prion proteins.
  • Cofactors play a crucial role in protein misfolding and aggregation.
  • The prion-like spread of α-synuclein contributes to neurodegeneration.

Conclusions:

  • The prion-like behavior of α-synuclein is a central mechanism in Parkinson's disease.
  • Understanding cofactors is vital for targeting neurodegenerative processes.
  • This shared mechanism highlights potential therapeutic strategies for multiple neurological disorders.